Find the latest news on Coya Therapeutics
News
| The ALS Association, Muscular Dystrophy Association, and ALS Finding a Cure Provide Additional Funding for Novel ALS Research |
|
| Coya Raises $10M to Advance T-cell Therapy Now in Phase 2 ALS Trial |
|
| Senior AbbVie liaison quits job to launch neuro startup, with sights set on ALS |
|
Press Releases
|
Apr 27, 2022
Coya Therapeutics Announces Annals of Neurology Publication Featuring Biomarker Data in ALS Patients Treated with Tregs Cell Therapy
|
|
|
Apr 22, 2022
Coya Therapeutics to Participate in B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
|
|
|
Dec 10, 2021
Coya Therapeutics Applauds U.S. House of Representatives for Passing ACT for ALS
|
|
Blog
|
Jun 28, 2021
The Forest Fire Behind Neurodegenerative Diseases
|
|
|
Jun 07, 2021
My Personal Journey to a Cure for ALS
|
|
|
Apr 28, 2021
A Serendipitous Moment
|
|
PRESENTATIONS
Events
|
Jun 11, 2021
Houston, TX., June 11, 2021 -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology... |
